Emerging insights on intestinal dysbiosis during bacterial infections

Current Opinion in Microbiology

Volumn 17, Issue 1, 2014, Pages 67-74

  Pham, Tu Anh N ^a   Lawley, Trevor D ^a  

^a WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL GENOME; BACTERIAL INFECTION; BACTERIAL TRANSMISSION; BACTERIAL VIRULENCE; DYSBIOSIS; ENTERITIS; GASTROINTESTINAL INFECTION; GENE EXPRESSION; HOMEOSTASIS; HUMAN; INTESTINE FLORA; MICROBIAL COMMUNITY; NONHUMAN; PATHOGENESIS; REVIEW;

ANIMALS; BACTERIAL INFECTIONS; DYSBIOSIS; HUMANS; INTESTINAL DISEASES; MICE; MICROBIOTA; MODELS, BIOLOGICAL;

EID: 84891123514     PISSN: 13695274     EISSN: 18790364     Source Type: Journal    
DOI: 10.1016/j.mib.2013.12.002     Document Type: Review

References (64)

1. Sommer F., Backhed F. The gut microbiota-masters of host development and physiology. Nat Rev Microbiol 2013, 11:227-238.
2. Dethlefsen L., McFall-Ngai M., Relman D.A. An ecological and evolutionary perspective on human-microbe mutualism and disease. Nature 2007, 449:811-818.
3. Stecher B., Hardt W.D. The role of microbiota in infectious disease. Trends Microbiol 2008, 16:107-114.
4. Medini D., Serruto D., Parkhill J., Relman D.A., Donati C., Moxon R., Falkow S., Rappuoli R. Microbiology in the post-genomic era. Nat Rev Microbiol 2008, 6:419-430.
5. Falkow S. What is a pathogen?. ASM News 1997, 63:359-365.
6. Eckburg P.B., Bik E.M., Bernstein C.N., Purdom E., Dethlefsen L., Sargent M., Gill S.R., Nelson K.E., Relman D.A. Diversity of the human intestinal microbial flora. Science 2005, 308:1635-1638.
7. Lozupone C.A., Stombaugh J., Gonzalez A., Ackermann G., Wendel D., Vazquez-Baeza Y., Jansson J.K., Gordon J.I., Knight R. Meta-analyses of studies of the human microbiota. Genome Res 2013, 23:1704-1714.
8. Qin J., Li R., Raes J., Arumugam M., Burgdorf K.S., Manichanh C., Nielsen T., Pons N., Levenez F., Yamada T., et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 2010, 464:59-65.
9. Hooper L.V., Macpherson A.J. Immune adaptations that maintain homeostasis with the intestinal microbiota. Nat Rev Immunol 2010, 10:159-169.
10. Kamada N., Seo S.U., Chen G.Y., Nunez G. Role of the gut microbiota in immunity and inflammatory disease. Nat Rev Immunol 2013, 13:321-335.
11. Lawley T.D., Walker A.W. Intestinal colonization resistance. Immunology 2013, 138:1-11.
12. Stecher B., Hardt W.D. Mechanisms controlling pathogen colonization of the gut. Curr Opin Microbiol 2011, 14:82-91.
13. Stecher B., Robbiani R., Walker A.W., Westendorf A.M., Barthel M., Kremer M., Chaffron S., Macpherson A.J., Buer J., Parkhill J., et al. Salmonella enterica serovar Typhimurium exploits inflammation to compete with the intestinal microbiota. PLoS Biol 2007, 5:2177-2189.
14. Lupp C., Robertson M.L., Wickham M.E., Sekirov I., Champion O.L., Gaynor E.C., Finlay B.B. Host-mediated inflammation disrupts the intestinal microbiota and promotes the overgrowth of Enterobacteriaceae. Cell Host Microbe 2007, 2:204.
15. Lawley T.D., Bouley D.M., Hoy Y.E., Gerke C., Relman D.A., Monack D.M. Host transmission of Salmonella enterica serovar Typhimurium is controlled by virulence factors and indigenous intestinal microbiota. Infect Immun 2008, 76:403-416.
16. Rupnik M., Wilcox M.H., Gerding D.N. Clostridium difficile infection: new developments in epidemiology and pathogenesis. Nat Rev Microbiol 2009, 7:526-536.
17. Keeney K.M., Finlay B.B. Enteric pathogen exploitation of the microbiota-generated nutrient environment of the gut. Curr Opin Microbiol 2011, 14:92-98.
18. Raffatellu M., George M.D., Akiyama Y., Hornsby M.J., Nuccio S.P., Paixao T.A., Butler B.P., Chu H., Santos R.L., Berger T., et al. Lipocalin-2 resistance confers an advantage to Salmonella enterica serotype Typhimurium for growth and survival in the inflamed intestine. Cell Host Microbe 2009, 5:476-486.
19. Winter S.E., Thiennimitr P., Winter M.G., Butler B.P., Huseby D.L., Crawford R.W., Russell J.M., Bevins C.L., Adams L.G., Tsolis R.M., et al. Gut inflammation provides a respiratory electron acceptor for Salmonella. Nature 2010, 467:426-429.
20. Huang Y., Suyemoto M., Garner C.D., Cicconi K.M., Altier C. Formate acts as a diffusible signal to induce Salmonella invasion. J Bacteriol 2008, 190:4233-4241.
21. Lawhon S.D., Maurer R., Suyemoto M., Altier C. Intestinal short-chain fatty acids alter Salmonella typhimurium invasion gene expression and virulence through BarA/SirA. Mol Microbiol 2002, 46:1451-1464.
22. Ng K.M., Ferreyra J.A., Higginbottom S.K., Lynch J.B., Kashyap P.C., Gopinath S., Naidu N., Choudhury B., Weimer B.C., Monack D.M., et al. Microbiota-liberated host sugars facilitate post-antibiotic expansion of enteric pathogens. Nature 2013, 502:96-99.
23. Buffie C.G., Jarchum I., Equinda M., Lipuma L., Gobourne A., Viale A., Ubeda C., Xavier J., Pamer E.G. Profound alterations of intestinal microbiota following a single dose of clindamycin results in sustained susceptibility to Clostridium difficile-induced colitis. Infect Immun 2012, 80:62-73.
24. Kaiser P., Diard M., Stecher B., Hardt W.D. The streptomycin mouse model for Salmonella diarrhea: functional analysis of the microbiota, the pathogen's virulence factors, and the host's mucosal immune response. Immunol Rev 2012, 245:56-83.
25. Lawley T.D., Clare S., Walker A.W., Stares M.D., Connor T.R., Raisen C., Goulding D., Rad R., Schreiber F., Brandt C., et al. Targeted restoration of the intestinal microbiota with a simple, defined bacteriotherapy resolves relapsing Clostridium difficile disease in mice. PLoS Pathog 2012, 8:e1002995.
26. Ubeda C., Taur Y., Jenq R.R., Equinda M.J., Son T., Samstein M., Viale A., Socci N.D., van den Brink M.R., Kamboj M., et al. Vancomycin-resistant Enterococcus domination of intestinal microbiota is enabled by antibiotic treatment in mice and precedes bloodstream invasion in humans. J Clin Invest 2010, 120:4332-4341.
27. Chang J.Y., Antonopoulos D.A., Kalra A., Tonelli A., Khalife W.T., Schmidt T.M., Young V.B. Decreased diversity of the fecal microbiome in recurrent Clostridium difficile-associated diarrhea. J Infect Dis 2008, 197:435-438.
28. Hoffmann C., Hill D.A., Minkah N., Kirn T., Troy A., Artis D., Bushman F. Community-wide response of the gut microbiota to enteropathogenic Citrobacter rodentium infection revealed by deep sequencing. Infect Immun 2009, 77:4668-4678.
29. Willing B.P., Russell S.L., Finlay B.B. Shifting the balance: antibiotic effects on host-microbiota mutualism. Nat Rev Microbiol 2011, 9:233-243.
30. Winter S.E., Winter M.G., Xavier M.N., Thiennimitr P., Poon V., Keestra A.M., Laughlin R.C., Gomez G., Wu J., Lawhon S.D., et al. Host-derived nitrate boosts growth of E. coli in the inflamed gut. Science 2013, 339:708-711.
31. Elinav E., Strowig T., Kau A.L., Henao-Mejia J., Thaiss C.A., Booth C.J., Peaper D.R., Bertin J., Eisenbarth S.C., Gordon J.I., et al. NLRP6 inflammasome regulates colonic microbial ecology and risk for colitis. Cell 2011, 145:745-757.
32. Maslowski K.M., Mackay C.R. Diet, gut microbiota and immune responses. Nat Immunol 2011, 12:5-9.
33. Reeves A.E., Theriot C.M., Bergin I.L., Huffnagle G.B., Schloss P.D., Young V.B. The interplay between microbiome dynamics and pathogen dynamics in a murine model of Clostridium difficile infection. Gut Microbes 2011, 2:145-158.
34. Gantois I., Ducatelle R., Pasmans F., Haesebrouck F., Hautefort I., Thompson A., Hinton J.C., Van Immerseel F. Butyrate specifically down-regulates salmonella pathogenicity island 1 gene expression. Appl Environ Microbiol 2006, 72:946-949.
35. Sekirov I., Tam N.M., Jogova M., Robertson M.L., Li Y., Lupp C., Finlay B.B. Antibiotic-induced perturbations of the intestinal microbiota alter host susceptibility to enteric infection. Infect Immun 2008, 76:4726-4736.
36. Endt K., Stecher B., Chaffron S., Slack E., Tchitchek N., Benecke A., Van Maele L., Sirard J.C., Mueller A.J., Heikenwalder M., et al. The microbiota mediates pathogen clearance from the gut lumen after non-typhoidal Salmonella diarrhea. PLoS Pathog 2010, 6:e1001097.
37. Stecher B., Chaffron S., Kappeli R., Hapfelmeier S., Freedrich S., Weber T.C., Kirundi J., Suar M., McCoy K.D., von Mering C., et al. Like will to like: abundances of closely related species can predict susceptibility to intestinal colonization by pathogenic and commensal bacteria. PLoS Pathog 2010, 6:e1000711.
38. Hajishengallis G., Darveau R.P., Curtis M.A. The keystone-pathogen hypothesis. Nat Rev Microbiol 2012, 10:717-725.
39. Powell N., Walker A.W., Stolarczyk E., Canavan J.B., Gokmen M.R., Marks E., Jackson I., Hashim A., Curtis M.A., Jenner R.G., et al. The transcription factor T-bet regulates intestinal inflammation mediated by interleukin-7 receptor+innate lymphoid cells. Immunity 2012, 37:674-684.
40. Stiefel U., Pultz N.J., Helfand M.S., Donskey C.J. Increased susceptibility to vancomycin-resistant Enterococcus intestinal colonization persists after completion of anti-anaerobic antibiotic treatment in mice. Infect Control Hosp Epidemiol 2004, 25:373-379.
41. Ayres J.S., Trinidad N.J., Vance R.E. Lethal inflammasome activation by a multidrug-resistant pathobiont upon antibiotic disruption of the microbiota. Nat Med 2012, 18:799-806.
42. Hughes D.T., Terekhova D.A., Liou L., Hovde C.J., Sahl J.W., Patankar A.V., Gonzalez J.E., Edrington T.S., Rasko D.A., Sperandio V. Chemical sensing in mammalian host-bacterial commensal associations. Proc Natl Acad Sci U S A 2010, 107:9831-9836.
43. Kamada N., Kim Y.G., Sham H.P., Vallance B.A., Puente J.L., Martens E.C., Nunez G. Regulated virulence controls the ability of a pathogen to compete with the gut microbiota. Science 2012, 336:1325-1329.
44. Merrell D.S., Butler S.M., Qadri F., Dolganov N.A., Alam A., Cohen M.B., Calderwood S.B., Schoolnik G.K., Camilli A. Host-induced epidemic spread of the cholera bacterium. Nature 2002, 417:642-645.
45. Wiles S., Dougan G., Frankel G. Emergence of a 'hyperinfectious' bacterial state after passage of Citrobacter rodentium through the host gastrointestinal tract. Cell Microbiol 2005, 7:1163-1172.
46. Schild S., Tamayo R., Nelson E.J., Qadri F., Calderwood S.B., Camilli A. Genes induced late in infection increase fitness of Vibrio cholerae after release into the environment. Cell Host Microbe 2007, 2:264-277.
47. Salyers A.A., Gupta A., Wang Y. Human intestinal bacteria as reservoirs for antibiotic resistance genes. Trends Microbiol 2004, 12:412-416.
48. Duerkop B.A., Clements C.V., Rollins D., Rodrigues J.L., Hooper L.V. A composite bacteriophage alters colonization by an intestinal commensal bacterium. Proc Natl Acad Sci U S A 2012, 109:17621-17626.
49. Matos R.C., Lapaque N., Rigottier-Gois L., Debarbieux L., Meylheuc T., Gonzalez-Zorn B., Repoila F., Lopes Mde F., Serror P. Enterococcus faecalis prophage dynamics and contributions to pathogenic traits. PLoS Genet 2013, 9:e1003539.
50. He M., Miyajima F., Roberts P., Ellison L., Pickard D.J., Martin M.J., Connor T.R., Harris S.R., Fairley D., Bamford K.B., et al. Emergence and global spread of epidemic healthcare-associated Clostridium difficile. Nat Genet 2013, 45:109-113.
51. He M., Sebaihia M., Lawley T.D., Stabler R.A., Dawson L.F., Martin M.J., Holt K.E., Seth-Smith H.M., Quail M.A., Rance R., et al. Evolutionary dynamics of Clostridium difficile over short and long time scales. Proc Natl Acad Sci U S A 2010, 107:7527-7532.
52. Stecher B., Denzler R., Maier L., Bernet F., Sanders M.J., Pickard D.J., Barthel M., Westendorf A.M., Krogfelt K.A., Walker A.W., et al. Gut inflammation can boost horizontal gene transfer between pathogenic and commensal Enterobacteriaceae. Proc Natl Acad Sci U S A 2012, 109:1269-1274.
53. Stecher B., Maier L., Hardt W.D. 'Blooming' in the gut: how dysbiosis might contribute to pathogen evolution. Nat Rev Microbiol 2013, 11:277-284.
54. Lawley T.D., Clare S., Walker A.W., Goulding D., Stabler R.A., Croucher N., Mastroeni P., Scott P., Raisen C., Mottram L., et al. Antibiotic treatment of Clostridium difficile carrier mice triggers a supershedder state, spore-mediated transmission, and severe disease in immunocompromised hosts. Infect Immun 2009, 77:3661-3669.
55. Deakin L.J., Clare S., Fagan R.P., Dawson L.F., Pickard D.J., West M.R., Wren B.W., Fairweather N.F., Dougan G., Lawley T.D. The Clostridium difficile spo0A gene is a persistence and transmission factor. Infect Immun 2012, 80:2704-2711.
56. Donskey C.J., Chowdhry T.K., Hecker M.T., Hoyen C.K., Hanrahan J.A., Hujer A.M., Hutton-Thomas R.A., Whalen C.C., Bonomo R.A., Rice L.B. Effect of antibiotic therapy on the density of vancomycin-resistant enterococci in the stool of colonized patients. N Engl J Med 2000, 343:1925-1932.
57. Willing B.P., Vacharaksa A., Croxen M., Thanachayanont T., Finlay B.B. Altering host resistance to infections through microbial transplantation. PLoS ONE 2011, 6:e26988.
58. Ubeda C., Bucci V., Caballero S., Djukovic A., Toussaint N.C., Equinda M., Lipuma L., Ling L., Gobourne A., No D., et al. Intestinal microbiota containing Barnesiella species cures vancomycin-resistant Enterococcus faecium colonization. Infect Immun 2013, 81:965-973.
59. van Nood E., Vrieze A., Nieuwdorp M., Fuentes S., Zoetendal E.G., de Vos W.M., Visser C.E., Kuijper E.J., Bartelsman J.F., Tijssen J.G., et al. Duodenal infusion of donor feces for recurrent Clostridium difficile. N Engl J Med 2013, 368:407-415.
60. Reeves A.E., Koenigsknecht M.J., Bergin I.L., Young V.B. Suppression of Clostridium difficile in the gastrointestinal tracts of germfree mice inoculated with a murine isolate from the family Lachnospiraceae. Infect Immun 2012, 80:3786-3794.
61. Adamu B.O., Lawley T.D. Bacteriotherapy for the treatment of intestinal dysbiosis caused by Clostridium difficile infection. Curr Opin Microbiol 2013.
62. Goodman A.L., Kallstrom G., Faith J.J., Reyes A., Moore A., Dantas G., Gordon J.I. Extensive personal human gut microbiota culture collections characterized and manipulated in gnotobiotic mice. Proc Natl Acad Sci U S A 2011, 108:6252-6257.
63. Lagier J.C., Armougom F., Million M., Hugon P., Pagnier I., Robert C., Bittar F., Fournous G., Gimenez G., Maraninchi M., et al. Microbial culturomics: paradigm shift in the human gut microbiome study. Clin Microbiol Infect 2012, 18:1185-1193.
64. Farris M.H., Olson J.B. Detection of Actinobacteria cultivated from environmental samples reveals bias in universal primers. Lett Appl Microbiol 2007, 45:376-381.